My watch list  

28 Current news of Lonza


You can refine your search further. Select from the filter options on the left to narrow down your results.

Lonza Starts 2017 with Outstanding First Quarter

Outlook 2017 upgraded


During the first quarter of 2017, Lonza achieved another record quarter in terms of sales and earnings. The healthy overall company performance resulted from particularly strong performance in the Pharma&Biotech segment and continued robust growth in the Specialty Ingredients segment. “Following ...


Lonza reports strong Q3 momentum

Guidance 2018 expected to be achieved one year ahead of time


Lonza recorded another strong quarter in terms of sales and earnings. The overall company results were a consequence of continued good performance in both the Specialty Ingredients and the Pharma&Biotech segments. “We have experienced a continuous growth pattern, which is further proof that our ...


Lonza Acquires Chemical Company Zelam Based in New Zealand


Lonza announced that it has acquired Zelam, a research-focused chemical company based in New Zealand, which develops and manufactures products for crop protection, specializing in fungicides, insecticides, herbicides, foliar nutrients and additives. Zelam also develops and manufactures products ...


Lonza announces price increase for three product lines


Lonza has announced that, due to price increases of key raw materials and tightening conditions in the marketplace, it will be implementing a 5% to 10% price increase for Hygiene and Water Treatment applications in Europe, Africa and the Middle East for the BardacTM, BarquatTM and LonzabacTM 12 ...


Collaboration announced between the Canton of Valais and Lonza


The State Council of the Canton of Valais and Lonza announced the establishment of a Coordinating Committee to address effectively the problem of mercury pollution between Visp and Niedergesteln, Switzerland. The Coordinating Committee will oversee various working groups. As a first action, Lonza ...


Lonza extends partnership with Pharmacyclics


Lonza announced it has established an agreement with Pharmacyclics, Inc. to support the commercial and clinical production of its first-in-class oral oncology drug, IMBRUVICA™ (Ibrutinib). This agreement follows a multi-year partnership, including the development and clinical manufacturing, ...


Lonza and Novoset: Introduction of thermoset polyimides for electronic and aerospace industries


Lonza Ltd and Novoset LLC announce the introduction of a new generation of thermoset polyimides. The new polyimides address shortcomings of conventional high temperature polyimides currently available in the market and will serve semiconductor packaging, aerospace, abrasives, composite tooling, ...


Lonza extends tender offer for all outstanding shares of Arch Chemicals common stock


Lonza Group Ltd announced that LG Acquisition Corp., an indirect wholly owned subsidiary of Lonza, has extended the expiration date for its previously announced tender offer for 100 percent of the outstanding shares of common stock of Arch Chemicals, Inc.. The tender offer is at a price of USD ...


Lonza to acquire Arch Chemicals


Lonza Group Ltd and Arch Chemicals, Inc. announced that they have signed an agreement pursuant to which Lonza has agreed to commence a tender offer for 100 percent of Arch Chemicals’ outstanding shares of common stock at a price of USD 47.20 per share in cash. Lonza’s offer represents a 36.7% ...


Ehrfeld Mikrotechnik BTS and Lonza cooperate in the microreactor technology


Ehrfeld Mikrotechnik BTS (EMB), a Bayer Technology Services company, and Lonza signed a worldwide manufacturing and distribution license agreement together with a cooperation and development agreement on the Lonza microreactor technology. Under the terms of the agreements, EMB will acquire a ...


Page 1 From 3
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE